LYSANDO
Lysando AG is market-leader for antimicrobial proteins, so-called Artilysin®s. Artilysin®s are a new class of molecules which show a high resistance stability and are at the same time microbiome - and environmentally friendly. Artilysin®s can be employed in all fields bacteria present a problem like Medical Devices, Human Pharmaceutics, Animal Health and Consumer Care.
Last updated on
About LYSANDO
Estimated Revenue
$1M-$10MEmployees
11-50Category
Location
City
TriesenbergState
TriesenbergCountry
LiechtensteinLYSANDO
Find your buyer within LYSANDO